A trial of more than 3,000 healthy full-term infants shows clesrovimab, a single-dose monoclonal antibody, reduced the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infection and RSV-associated…
Category: 6. Business
-

IMS 2025: Improving Patient Experience with On-Body Injector Administration of Isatuximab-Irfc | Pharmacy Times
Xavier Leleu, MD, PhD, head of the department of hematology and myeloma clinic at Hôpital La Mileterie in Poitiers, France, sat down with Pharmacy Times® at the 22nd annual International Myeloma Society (IMS) meeting and exposition in Toronto,…
Continue Reading
-

AI safety and security can enable innovation in Global Majority countries
A central tension in contemporary AI governance debates concerns the perceived trade-off between advancing innovation and ensuring safety and security. AI safety, which concerns preventing harm from advanced systems ranging from…
Continue Reading
-

Too tricky to cancel: Amazon faces US trial over alleged Prime subscription deceptions | Technology
Amazon went to trial on Monday in a US government lawsuit that accuses the e-commerce giant of using tricks to enroll millions of customers in its Prime subscription service and then making it nearly impossible to cancel.
The Federal Trade…
Continue Reading
-

Nvidia, AMD Seals $670M GPU Order As IREN Doubles AI Cloud Power
This article first appeared on GuruFocus.
Sep 22 – IREN Limited (NASDAQ:IREN) has taken another big step in its push into artificial intelligence infrastructure.
On Monday, the data center operator and bitcoin miner said it will spend…
Continue Reading
-

Satellos submits SAT-3247 IND for phase 2 study in children with DMD
Satellos submits SAT-3247 IND to FDA for phase 2 study in children with Duchenne muscular dystrophy | Image credit: Contemporary Pediatrics
On September 22, 2025, Satellos Bioscience submitted an Investigational New Drug (IND) application to the…
Continue Reading
-

Dara-KRd Regimen Displays Prolonged PFS in Newly Diagnosed Multiple Myeloma
Induction and consolidation with daratumumab (Darzalex), lenalidomide (Revlimid), and carfilzomib (Kyprolis) plus dexamethasone (Dara-KRd) followed by daratumumab/lenalidomide maintenance exhibited prolonged progression-free survival (PFS) in…
Continue Reading
-
Phase 3 Data Put Povorcitinib on HS Radar – Medscape
- Phase 3 Data Put Povorcitinib on HS Radar Medscape
- Incyte stock rating reiterated by Citizens JMP amid promising drug data Investing.com
- INCY Announces New Late-Stage Data on Skin Disease Drug Yahoo Finance
- Povorcitinib Improves Moderate to…
Continue Reading
-

Apple’s stock surges to a 2025 high on hot iPhone 17 demand. Can the rally continue?
By Christine Ji
Strong early demand for the new iPhone is fueling a rally in Apple’s stock, but some analysts are seeing mixed signals for the pricier models
Ship dates for the iPhone 17 are longer than they were for the iPhone…
Continue Reading

